Doxorubicin: all 842 studies that test it
Page 8 of 9. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple MyelomaCompletedNCT00135187Not applicable
- Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate CancerTerminatedNCT00132756Phase 1/2
- Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer PatientsCompletedNCT00129896Phase 1/2
- Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
- Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer PatientsCompletedNCT00128778Phase 4
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2
- Doxorubicin Pharmacokinetic (PK) StudyWithdrawnNCT00124956Phase 1/2
- Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast CancerCompletedNCT00123929Phase 2
- Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple MyelomaCompletedNCT00116961Phase 2
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic PurpuraStatus unknownNCT00107913Phase 2
- A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue SarcomaCompletedNCT00102609Phase 1
- A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast CancerCompletedNCT00102219Phase 2
- Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryCompletedNCT00098579Phase 1
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast CancerCompletedNCT00093834Phase 1
- MRI Sarcoma Non Invasive ThermometryCompletedNCT00093509Phase 1/2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple MyelomaCompletedNCT00088855Phase 2
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNCT00086801Phase 2
- To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and OlderTerminatedNCT00082095Phase 3
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNCT00080795Phase 2
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00079261Phase 2
- Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)Status unknownNCT00079027Phase 3
- 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid TumorsCompletedNCT00079014Phase 1
- Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and NeckCompletedNCT00077428Phase 2
- Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid CancerTerminatedNCT00077103Phase 1/2
- Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaCompletedNCT00075634Phase 1
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerWithdrawnNCT00074139Phase 1
- Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis FungoidesCompletedNCT00074087Phase 2
- Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00070447Phase 2
- Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaCompletedNCT00070083Phase 1
- Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00061984Phase 3
- Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerCompletedNCT00061867Phase 1
- T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma PatientsTerminatedNCT00057382Phase 2/3
- Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00053768Phase 3
- Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00052390Phase 2
- Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial CancerCompletedNCT00052312Phase 2
- Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast CancerCompletedNCT00049114Phase 2
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00047229Phase 2
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast CancerCompletedNCT00044993Phase 2
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
- Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00030472Phase 2
- Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumCompletedNCT00028756Phase 3
- PS-341 and Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNCT00023855Phase 1
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
- Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsCompletedNCT00020124Phase 1
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
- Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent SarcomaWithdrawnNCT00017160Phase 2
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00016302Not applicable
- Combination Chemotherapy in Treating Patients With Bladder CancerCompletedNCT00014534Phase 3
- Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate CancerCompletedNCT00014352Phase 2
- Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver CancerCompletedNCT00012324Phase 3
- Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple MyelomaCompletedNCT00008242Phase 2
- Octreotide and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00008073Phase 1
- Adjuvant Stage 2-3A Breast Cancer With Positive Lymph NodesCompletedNCT00007904Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
- Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast CancerStatus unknownNCT00006433Phase 2
- Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00006377Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006372Phase 1
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaCompletedNCT00006125Phase 2
- Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2
- Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005980Phase 2
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00005861Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005830Phase 1
- SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast CancerCompletedNCT00005822Phase 1
- Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNCT00005800Phase 2
- Chemotherapy in Treating Patients With Sarcoma of the UterusCompletedNCT00005643Phase 2
- Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesCompletedNCT00004930Phase 1
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerCompletedNCT00004906Phase 2
- Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00004248Phase 2
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerStatus unknownNCT00004236Phase 2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
- Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
- Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue SarcomaCompletedNCT00004123Phase 1
- Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00004109Phase 1
- Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid CancerCompletedNCT00004048Phase 1/2
- Liposomal Doxorubicin in Treating Patients With Prostate CancerCompletedNCT00004014Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
- Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00003953Phase 2
- Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerCompletedNCT00003927Phase 1
- VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung CancerTerminatedNCT00003847Phase 2
- Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung CancerStatus unknownNCT00003696Phase 3
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
- Combination Chemotherapy in Treating Patients With Metastatic Kidney CancerCompletedNCT00003683Phase 2
- Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate CancerTerminatedNCT00003682Phase 3
- Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
- Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00003352Phase 2
- Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00003311Phase 2
- Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00003212Phase 3
- Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersCompletedNCT00003207Phase 1
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach CancerCompletedNCT00003172Phase 2